{"id":"cdc7","name":"CDC7","symbol":"CDC7","route":"/targets/cdc7/","asOf":"2026-11-03","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1745","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000097046","uniprot":"https://www.uniprot.org/uniprotkb/O00311/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/O00311","open-targets":"https://platform.opentargets.org/target/ENSG00000097046","civic":"https://civicdb.org/genes/8317/summary","oncokb":"https://www.oncokb.org/gene/CDC7","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=CDC7","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=CDC7","depmap":"https://depmap.org/portal/gene/CDC7?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000097046-CDC7","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/8317","omim":"https://www.omim.org/entry/603311"}],"products":[{"id":"sgr-2921","name":"SGR-2921","status":"phase-1","modality":"Small molecule (oral)","route":"/drugs/sgr-2921/"}],"trials":[{"id":"nct05961839","name":"Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome","nct":"NCT05961839","phase":"1","status":"historic"}],"pathways":[],"companies":["schrodinger"],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}